000863617 001__ 863617
000863617 005__ 20220930130214.0
000863617 0247_ $$2doi$$a10.1186/s12885-019-5841-8
000863617 0247_ $$2Handle$$a2128/22449
000863617 0247_ $$2pmid$$apmid:31242896
000863617 0247_ $$2WOS$$aWOS:000473007000002
000863617 0247_ $$2altmetric$$aaltmetric:62812291
000863617 037__ $$aFZJ-2019-03629
000863617 082__ $$a610
000863617 1001_ $$0P:(DE-HGF)0$$aEndepols, Heike$$b0
000863617 245__ $$aPeripheral ganglia in healthy rats as target structures for the evaluation of PSMA imaging agents
000863617 260__ $$aHeidelberg$$bSpringer$$c2019
000863617 3367_ $$2DRIVER$$aarticle
000863617 3367_ $$2DataCite$$aOutput Types/Journal article
000863617 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1562830920_29363
000863617 3367_ $$2BibTeX$$aARTICLE
000863617 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000863617 3367_ $$00$$2EndNote$$aJournal Article
000863617 520__ $$aBACKGROUND:The recent implementation of PET with prostate specific membrane antigen (PSMA)-specific radiotracers into the clinical practice has resulted in the significant improvement of accuracy in the detection of prostate carcinoma (PCa). PSMA-expression in ganglia has been regarded as an important pitfall in prostate carcinoma-PET diagnostics but has not found any practical use for diagnosis or therapy.METHODS:We explored this phenomenon and demonstrated the applicability of peripheral ganglia in healthy rats as surrogates for small PSMA positive lesions for the preclinical evaluation of diagnostic PCa PET probes. Healthy rats were measured with PET/CT using the tracers [18F]DCFPyL, [Al18F]PSMA-11 and [68Ga]PSMA-11. Sections of ganglia were stained with an anti-PSMA antibody. [18F]DCFPyL uptake in ganglia was compared to that in LNCaP tumor xenografts in mice.RESULTS:Whereas [18F]DCFPyL and [68Ga]PSMA-11 were stable in vivo and accumulated in peripheral ganglia, [Al18F]PSMA-11 suffered from fast in vivo deflourination resulting in high bone uptake. Ganglionic PSMA expression was confirmed by immunohistochemistry. [18F]DCFPyL uptake and signal-to-noise ratio in the superior cervical ganglion was not significantly different from LNCaP xenografts.CONCLUSIONS:Our results demonstrated the non-inferiority of the novel model compared to conventionally used tumor xenografts in immune compromised rodents with regard to reproducibility and stability of the PSMA signal. Furthermore, the model involves less expense and efforts while it is permanently available and avoids tumor-growth associated animal morbidity and distress. To the best of our knowledge, this is the first tumor-free model suitable for the in vivo evaluation of tumor imaging agents.
000863617 536__ $$0G:(DE-HGF)POF3-573$$a573 - Neuroimaging (POF3-573)$$cPOF3-573$$fPOF III$$x0
000863617 588__ $$aDataset connected to CrossRef
000863617 7001_ $$0P:(DE-HGF)0$$aMorgenroth, Agnieszka$$b1
000863617 7001_ $$0P:(DE-Juel1)176188$$aZlatopolskiy, Boris D.$$b2$$ufzj
000863617 7001_ $$0P:(DE-Juel1)169356$$aKrapf, Philipp$$b3$$ufzj
000863617 7001_ $$0P:(DE-Juel1)166483$$aZischler, Johannes$$b4
000863617 7001_ $$0P:(DE-Juel1)169321$$aRicharz, Raphael$$b5
000863617 7001_ $$0P:(DE-HGF)0$$aMuñoz Vásquez, Sergio$$b6
000863617 7001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b7$$eCorresponding author
000863617 7001_ $$0P:(DE-Juel1)132318$$aMottaghy, Felix M.$$b8$$ufzj
000863617 773__ $$0PERI:(DE-600)2041352-X$$a10.1186/s12885-019-5841-8$$gVol. 19, no. 1, p. 633$$n1$$p633$$tBMC cancer$$v19$$x1471-2407$$y2019
000863617 8564_ $$uhttps://juser.fz-juelich.de/record/863617/files/document%2851%29.pdf$$yOpenAccess
000863617 8564_ $$uhttps://juser.fz-juelich.de/record/863617/files/document%2851%29.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000863617 8767_ $$92019-09-23$$d2019-10-10$$eAPC$$jDeposit$$lDeposit: BMC$$p7059648542019819
000863617 909CO $$ooai:juser.fz-juelich.de:863617$$popenCost$$pVDB$$pdriver$$pOpenAPC$$popen_access$$popenaire$$pdnbdelivery
000863617 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)176188$$aForschungszentrum Jülich$$b2$$kFZJ
000863617 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)169356$$aForschungszentrum Jülich$$b3$$kFZJ
000863617 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166483$$aForschungszentrum Jülich$$b4$$kFZJ
000863617 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b7$$kFZJ
000863617 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)132318$$aForschungszentrum Jülich$$b8$$kFZJ
000863617 9131_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000863617 9141_ $$y2019
000863617 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000863617 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000863617 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search
000863617 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bBMC CANCER : 2017
000863617 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal
000863617 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ
000863617 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000863617 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000863617 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000863617 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000863617 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC
000863617 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000863617 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5
000863617 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000863617 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central
000863617 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000863617 920__ $$lyes
000863617 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000863617 9801_ $$aFullTexts
000863617 980__ $$ajournal
000863617 980__ $$aVDB
000863617 980__ $$aUNRESTRICTED
000863617 980__ $$aI:(DE-Juel1)INM-5-20090406
000863617 980__ $$aAPC